MEI Pharma Inc (MEIP)
2.95
+0.05
(+1.72%)
USD |
NASDAQ |
May 31, 16:00
2.89
-0.06
(-2.03%)
After-Hours: 20:00
MEI Pharma Enterprise Value: -36.90M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -36.90M |
| May 30, 2024 | -37.23M |
| May 29, 2024 | -37.10M |
| May 28, 2024 | -36.13M |
| May 24, 2024 | -35.90M |
| May 23, 2024 | -35.66M |
| May 22, 2024 | -35.30M |
| May 21, 2024 | -35.76M |
| May 20, 2024 | -35.83M |
| May 17, 2024 | -35.56M |
| May 16, 2024 | -37.03M |
| May 15, 2024 | -35.86M |
| May 14, 2024 | -35.50M |
| May 13, 2024 | -35.76M |
| May 10, 2024 | -36.43M |
| May 09, 2024 | -36.10M |
| May 08, 2024 | -35.50M |
| May 07, 2024 | -35.70M |
| May 06, 2024 | -35.23M |
| May 03, 2024 | -36.16M |
| May 02, 2024 | -36.16M |
| May 01, 2024 | -36.16M |
| April 30, 2024 | -36.23M |
| April 29, 2024 | -36.03M |
| April 26, 2024 | -36.23M |
| Date | Value |
|---|---|
| April 25, 2024 | -35.90M |
| April 24, 2024 | -34.83M |
| April 23, 2024 | -34.35M |
| April 22, 2024 | -34.10M |
| April 19, 2024 | -34.90M |
| April 18, 2024 | -34.90M |
| April 17, 2024 | -34.50M |
| April 16, 2024 | -35.23M |
| April 15, 2024 | -34.90M |
| April 12, 2024 | -34.76M |
| April 11, 2024 | -32.37M |
| April 10, 2024 | -31.50M |
| April 09, 2024 | -31.10M |
| April 08, 2024 | -31.03M |
| April 05, 2024 | -31.57M |
| April 04, 2024 | -30.23M |
| April 03, 2024 | -29.57M |
| April 02, 2024 | -29.90M |
| April 01, 2024 | -30.67M |
| March 28, 2024 | -32.83M |
| March 27, 2024 | -33.36M |
| March 26, 2024 | -33.76M |
| March 25, 2024 | -33.68M |
| March 22, 2024 | -33.96M |
| March 21, 2024 | -35.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.34M
Minimum
Mar 28 2022
362.99M
Maximum
Jun 23 2020
52.97M
Average
60.23M
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 346.63B |
| United Therapeutics Corp | 10.11B |
| Macrogenics Inc | 71.31M |
| Voyager Therapeutics Inc | 57.34M |
| Moderna Inc | 46.11B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.127M |
| Total Expenses (Quarterly) | 9.829M |
| EPS Diluted (Quarterly) | -1.37 |
| Earnings Yield | 132.9% |
| Operating Earnings Yield | 186.9% |
| Normalized Earnings Yield | 207.20 |